BioSpace News Archive

Business

Medasource: Depth and Breadth in Life Sciences and Healthcare Consulting

Michael Haas, Medasource’s Pharmaceutical & Life Sciences Vertical Director, describes the company as a “national healthcare consulting and project services company.”

October 7, 2020
·
2 min read
·
Mark Terry
BioSpace Global Roundup, Oct. 8

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

October 7, 2020
·
5 min read
·
Alex Keown
Drug Development

Bristol Myers Squibb Announces Phase III Results Exploring the Potential of Opdivo

Bristol Myers Squibb announced today that its Phase III CheckMate -816 trial met its primary endpoint of pathologic complete response (pCR) in patients with resectable non-small cell lung cancer.

October 7, 2020
·
3 min read
·
Krystle Vermes
Policy

White House Reverses Course, Approves New FDA COVID-19 Vaccine Guidelines

The new guidelines posted Tuesday by the FDA, call for vaccine developers to follow patients dosed with the experimental medication for at least two months before seeking Emergency Use Authorization.

October 7, 2020
·
3 min read
·
Alex Keown
Biotech Bay

Roche Carves Way into CF Space with Portfolio Acquisition

This morning, the Swiss pharma giant acquired a portfolio of experimental cystic fibrosis therapies, including a candidate that has the potential to treat all patients with this disease.

October 7, 2020
·
2 min read
·
Alex Keown
Policy

Promising Early Data Prompts Eli Lilly to Seek EUA for COVID-19 Antibody Treatment

Eli Lilly is seeking Emergency Use Authorization for its antibody therapy, LY-CoV555, for the treatment of high-risk patients with recently diagnosed mild-to-moderate coronavirus disease 2019 (COVID-19).

October 7, 2020
·
2 min read
·
Brandon May
Drug Development

Fluorescent Quantum Dot Tool Lets Researchers Study SARS-CoV-2 Without Risk of Infection

A new, nanoparticle tool mimics the way the SARS-CoV-2 virus infects a cell, letting scientists perform vital COVID-19 research without the risk of becoming infected themselves.

October 7, 2020
·
4 min read
·
Gail Dutton
Business

CRISPR Pioneers Doudna and Charpentier Win Nobel Prize in Chemistry

There is little doubt that CRISPR gene editing is and will continue to revolutionize biology and medicine. The Nobel Committee confirmed their belief in that by awarding the Nobel Prize in Chemistry to Emmanuelle Charpentier and Jennifer A. Doudna for their discovery and development of CRISPR.

October 7, 2020
·
3 min read
·
Mark Terry
Business

Whistleblower and Former BARDA Director Rick Bright Resigns from Government

In his resignation, Bright said that the Trump administration “ignores scientific expertise, overrules public health guidance and disrespects career scientists.”

October 7, 2020
·
3 min read
·
Mark Terry
Biohacking Market | Technological Advancement in the Biohacking Market Landscape Set to Drive Growth

Do it Yourself biology or biohacking covers a range of interesting activities. The broad term includes altering biology, tracking sleep, experimenting scientifically on organisms like yeast, and fighting aging.

October 7, 2020
·
3 min read